Mild induced hypothermia and coagulation and platelet function in patients with septic shock: Secondary outcome of a randomized trial

被引:4
作者
Itenov, Theis S. [1 ,2 ,3 ,12 ]
Kromann, Maria E. [1 ]
Ostrowski, Sisse R. [3 ,4 ]
Bestle, Morten H. [3 ,5 ,6 ]
Mohr, Thomas [6 ]
Gyldensted, Louise
Lindhardt, Anne [5 ]
Thormar, Katrin [2 ]
Sessler, Daniel I. [7 ]
Juffermans, Nicole P. [8 ,9 ]
Lundgren, Jens D. [1 ,3 ]
Jensen, Jens-Ulrik [1 ,3 ,10 ,11 ]
机构
[1] Copenhagen Univ Hosp, Dept Infect Dis, CHIPPERSIMUNE, Rigshosp, Copenhagen, Denmark
[2] Copenhagen Univ Hosp Bispebjerg, Dept Anesthesiol, Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[4] Rigshosp, Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark
[5] Copenhagen Univ Hosp North Zealand, Dept Anesthesia & Intens Care, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Herlev Gentofte, Dept Anesthesiol, Copenhagen, Denmark
[7] Cleveland Clin, Anesthesiol Inst, Dept Outcomes Res, Cleveland, OH USA
[8] OLVG Hosp, Dept Intens Care, Amsterdam, Netherlands
[9] Amsterdam Univ Med Ctr, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands
[10] Copenhagen Univ Hosp Gentofte, Dept Internal Med, Resp Sect, Copenhagen, Denmark
[11] Outcomes Res Consortium, Cleveland, OH USA
[12] Bispebjerg Hosp, Dept Anesthesiol & Crit Care, Bispebjerg Bakke 23, DK-2400 Copenhagen, Capital Region, Denmark
基金
新加坡国家研究基金会;
关键词
coagulopathy; sepsis; septic shock; therapeutic hypothermia; TARGETED TEMPERATURE MANAGEMENT; CARDIAC-ARREST; BLOOD-COAGULATION; COAGULOPATHY; INFLAMMATION; SURVIVAL; ACIDOSIS; SEPSIS; THROMBOELASTOMETRY; HEMOSTASIS;
D O I
10.1111/aas.14254
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Coagulation abnormalities and microthrombi contribute to septic shock, but the impact of body temperature regulation on coagulation in patients with sepsis is unknown. We tested the hypothesis that mild induced hypothermia reduces coagulation and platelet aggregation in patients with septic shock. Secondary analysis of randomized controlled trial. Adult patients with septic shock who required mechanical ventilation from eight intensive care units in Denmark were randomly assigned to mild induced hypothermia for 24 h or routine thermal management. Viscoelastography and platelet aggregation were assessed at trial inclusion, after 12 h of thermal management, and 24 h after inclusion. A total of 326 patients were randomized to mild induced hypothermia (n = 163) or routine thermal management (n = 163). Mild induced hypothermia slightly prolonged activated partial thromboplastin time and thrombus initiation time (R time 8.0 min [interquartile range, IQR 6.6-11.1] vs. 7.2 min [IQR 5.8-9.2]; p =.004) and marginally inhibited thrombus propagation (angle 68 degrees [IQR 59-73] vs. 71 degrees [IQR 63-75]; p =.014). The effect was also present after 24 h. Clot strength remained unaffected (MA 71 mm [IQR 66-76] with mild induced hypothermia vs. 72 mm (65-77) with routine thermal management, p =.9). The proportion of patients with hyperfibrinolysis was not affected (0.7% vs. 3.3%; p =.19), but the proportion of patients with no fibrinolysis was high in the mild hypothermia group (8.8% vs. 40.4%; p <.001). The mild induced hypothermia group had lower platelet aggregation: ASPI 85U (IQR 50-113) versus 109U (IQR 74-148, p <.001), ADP 61U (IQR 40-83) versus 79 U (IQR 54-101, p <.001), TRAP 108 (IQR 83-154) versus 119 (IQR 94-146, p =.042) and COL 50U (IQR 34-66) versus 67U (IQR 46-92, p <.001). In patients with septic shock, mild induced hypothermia slightly impaired clot initiation, but did not change clot strength. Platelet aggregation was slightly impaired. The effect of mild induced hypothermia on viscoelastography and platelet aggregation was however not in a range that would have clinical implications. We did observe a substantial reduction in fibrinolysis.
引用
收藏
页码:909 / 917
页数:9
相关论文
共 50 条
  • [41] IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock:: A randomized, controlled, multiple-center trial
    Hentrich, M
    Fehnle, K
    Ostermann, H
    Kienast, J
    Cornely, O
    Salat, C
    Übelacker, R
    Buchheidt, D
    Behre, G
    Hiddemann, W
    Schiel, X
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (05) : 1319 - 1325
  • [42] High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial
    Chung, Kevin K.
    Coates, Elsa C.
    Smith, David J., Jr.
    Karlnoski, Rachel A.
    Hickerson, William L.
    Arnold-Ross, Angela L.
    Mosier, Michael J.
    Halerz, Marcia
    Sprague, Amy M.
    Mullins, Robert F.
    Caruso, Daniel M.
    Albrecht, Marlene
    Arnoldo, Brett D.
    Burris, Agnes M.
    Taylor, Sandra L.
    Wolf, Steven E.
    [J]. CRITICAL CARE, 2017, 21
  • [43] Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
    Lertwattanachai, Tospon
    Montakantikul, Preecha
    Tangsujaritvijit, Viratch
    Sanguanwit, Pitsucha
    Sueajai, Jetjamnong
    Auparakkitanon, Saranya
    Dilokpattanamongkol, Pitchaya
    [J]. JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [44] Clinical outcomes of empirical high-dose meropenem in critically ill patients with sepsis and septic shock: a randomized controlled trial
    Tospon Lertwattanachai
    Preecha Montakantikul
    Viratch Tangsujaritvijit
    Pitsucha Sanguanwit
    Jetjamnong Sueajai
    Saranya Auparakkitanon
    Pitchaya Dilokpattanamongkol
    [J]. Journal of Intensive Care, 8
  • [45] Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
    Unger, Martin
    Morelli, Andrea
    Singer, Mervyn
    Radermacher, Peter
    Rehberg, Sebastian
    Trimmel, Helmut
    Joannidis, Michael
    Heinz, Gottfried
    Cerny, Vladimir
    Dostal, Pavel
    Siebers, Christian
    Guarracino, Fabio
    Pratesi, Francesca
    Biancofiore, Gianni
    Girardis, Massimo
    Kadlecova, Pavla
    Bouvet, Olivier
    Zoerer, Michael
    Grohmann-Izay, Barbara
    Krejcy, Kurt
    Klade, Christoph
    Krumpl, Guenther
    [J]. TRIALS, 2018, 19
  • [46] Proinflammatory modifications of lipoprotein structure and function in patients with septic shock: relationship to outcome
    Peters, CJ
    Nanjee, MN
    Gordon, AC
    Miller, NE
    Hinds, CJ
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2002, 89 (02) : 361P - 361P
  • [47] Mild Hypothermia After Intravenous Thrombolysis in Patients With Acute Stroke A Randomized Controlled Trial
    Piironen, Katja
    Tiainen, Marjaana
    Mustanoja, Satu
    Kaukonen, Kirsi-Maija
    Meretoja, Atte
    Tatlisumak, Turgut
    Kaste, Markku
    [J]. STROKE, 2014, 45 (02) : 486 - 491
  • [48] Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography—a randomized controlled trial
    Junyi Wang
    Xinjing Gao
    Zhengzhong He
    Jinxiang Wang
    Guowu Xu
    Tong Li
    [J]. BMC Anesthesiology, 23
  • [49] A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial
    Lin, Shu-Min
    Huang, Chien-Da
    Lin, Horng-Chyuan
    Liu, Chien-Ying
    Wang, Chun-Hua
    Kuo, Han-Pin
    [J]. SHOCK, 2006, 26 (06): : 551 - 557
  • [50] Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial
    Linden, Anja
    Spangfors, M.
    Olsen, M. H.
    Fisher, J.
    Lilja, G.
    Sjovall, F.
    Jungner, M.
    Lengquist, M.
    Kander, T.
    Samuelsson, L.
    Johansson, J.
    Palmnas, E.
    Unden, J.
    Oras, J.
    Cronhjort, M.
    Chew, M.
    Linder, A.
    Lipcsey, M.
    Nielsen, N.
    Jakobsen, J. C.
    Bentzer, P.
    [J]. CRITICAL CARE, 2024, 28 (01)